Relating to the regulation of products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and permits; imposing fees; creating criminal offenses; authorizing an administrative penalty.
SB 3 substantially rewrites Texas law governing hemp-derived consumable products. The bill narrows the category of lawful consumable hemp products by limiting them to products containing only cannabidiol (CBD) or cannabigerol (CBG), while prohibiting products with any other cannabinoid, including synthetic or artificial cannabinoids. It creates a new product-registration system administered by the Health and Human Services Commission, requires manufacturers and retailers to obtain licenses or registrations, imposes significant fees, and mandates product testing, labeling, QR-code verification, and public product listings. It also restricts packaging and marketing practices, especially those that could appeal to minors or imply medical use.
The bill adds multiple criminal offenses and administrative enforcement tools. It makes it a felony to manufacture, deliver, or possess with intent to deliver noncompliant consumable hemp products, and creates misdemeanor offenses for possession, sales to persons under 21, sales near schools, delivery by courier or mail, false lab reports, and sales without required licensing or registration. It also authorizes the department to revoke or suspend licenses and registrations and to assess administrative penalties of up to $10,000 per violation. Several existing provisions in the Health and Safety Code are repealed or revised to align the hemp code with the bill’s new restrictions.
In practical terms, the bill would have a major impact on hemp processors, manufacturers, retailers, laboratories, and consumers in Texas. Businesses would face new compliance costs, including $10,000 licensing fees per processing/manufacturing location, a $20,000 annual retailer registration fee per location, and a $500 fee for each product registration. Retailers would also need to ensure age verification, product labeling, and premises access for inspections, while consumers would see a much narrower range of hemp-derived products available for sale. The bill also exempts certain research activities and low-THC cannabis regulated under other law.
The overall sentiment in the legislative record appears mixed but ultimately supportive in the chambers, with the bill advancing on mostly party-line or divided votes and several amendments considered. The Senate passed the bill with a 26-5 vote, and the House passed it 87-54 with one present not voting, indicating meaningful support but also substantial opposition. The governor later vetoed the bill, suggesting the final executive view was not aligned with the enacted legislative package.
The main points of contention appear to be the bill’s breadth and severity. Critics likely focused on the high fees, the new criminal penalties, the restriction of lawful hemp products to only CBD and CBG, and the ban on products containing other cannabinoids that are common in the hemp market. Supporters appear to have emphasized consumer safety, youth access restrictions, product testing, and tighter oversight of intoxicating or misleading hemp products. The bill’s packaging rules, school-zone restrictions, and prohibition on marketing attractive to minors also suggest a strong public-safety and enforcement rationale that may have driven support, while industry stakeholders likely objected to the compliance burden and market contraction.
SB 3 would amend Chapter 443 of the Health and Safety Code to create a much more restrictive regulatory framework for hemp-derived consumable products. It would impose licensing, registration, testing, labeling, fee, inspection, and reporting requirements; prohibit most hemp-derived cannabinoids other than CBD and CBG; and establish new criminal and administrative penalties for noncompliance. It also repeals or revises existing hemp provisions to conform to the new scheme, affecting manufacturers, processors, retailers, laboratories, and enforcement agencies statewide.
The bill appears to have had cautious but significant support in both chambers, as reflected by passage in the Senate and House, but also notable opposition, especially in the House. The vote pattern suggests legislators were divided over how far Texas should go in regulating hemp products, with supporters favoring tighter safety and youth-protection rules and opponents likely concerned about overregulation and the impact on lawful hemp commerce. The governor’s veto indicates the final outcome remained controversial even after legislative approval.
The most contentious issues were the bill’s strict limitation of lawful hemp products to CBD and CBG, the large licensing and registration fees, and the creation of felony and misdemeanor offenses for possession, sale, delivery, and manufacturing of noncompliant products. Retail and manufacturing stakeholders likely objected to the cost and feasibility of compliance, while public-safety advocates likely supported the age restrictions, school-zone limits, packaging rules, and bans on child-appealing or misleading products. The bill also raised concerns about enforcement scope, including mandatory QR-code labeling, public product registries, and inspection access for law enforcement.